SonoScape Medical Corp (300633) — Tangible Net Worth Ratio

Latest as of March 2026: 95.6%

SonoScape Medical Corp (300633) has a Tangible Net Worth Ratio of 95.6% as of March 2026. This metric is calculated by deducting intangible assets (CN¥143.06 Million) from net assets (CN¥3.26 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See SonoScape Medical Corp (300633) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

95.6%
Tangible equity / total equity

Net Assets (Equity)

CN¥3.26 Billion
CNY

Intangible Assets

CN¥143.06 Million
Goodwill, patents, brand value

Total Assets

CN¥4.30 Billion
CNY

SonoScape Medical Corp Tangible Net Worth Ratio (2012–2025)

This chart shows how SonoScape Medical Corp's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 95.6%, reflecting net assets of CN¥3.26 Billion with intangible assets of CN¥143.06 Million CNY. See operational self-sufficiency of SonoScape Medical Corp to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for SonoScape Medical Corp (2012–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for SonoScape Medical Corp from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see SonoScape Medical Corp (300633) total market value.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 95.6% CN¥3.26 Billion CN¥145.07 Million CN¥4.41 Billion ▲ +0.6 pp
2024 95.0% CN¥3.11 Billion CN¥155.65 Million CN¥4.31 Billion ▲ +0.2 pp
2023 94.8% CN¥3.15 Billion CN¥164.85 Million CN¥3.77 Billion ▲ +0.9 pp
2022 93.8% CN¥2.74 Billion CN¥169.37 Million CN¥3.54 Billion ▲ +1.4 pp
2021 92.4% CN¥2.36 Billion CN¥179.06 Million CN¥3.02 Billion ▲ +5.5 pp
2020 86.9% CN¥1.34 Billion CN¥176.63 Million CN¥2.25 Billion ▼ -8.0 pp
2019 94.8% CN¥1.40 Billion CN¥72.39 Million CN¥2.41 Billion ▲ +0.3 pp
2018 94.5% CN¥1.31 Billion CN¥71.46 Million CN¥1.84 Billion ▲ +0.9 pp
2017 93.7% CN¥1.06 Billion CN¥67.06 Million CN¥1.34 Billion ▲ +3.6 pp
2016 90.1% CN¥720.11 Million CN¥71.43 Million CN¥1.02 Billion ▲ +3.8 pp
2015 86.3% CN¥566.21 Million CN¥77.60 Million CN¥935.73 Million ▲ +4.6 pp
2014 81.7% CN¥444.81 Million CN¥81.58 Million CN¥858.30 Million ▲ +5.4 pp
2013 76.2% CN¥365.08 Million CN¥86.81 Million CN¥625.75 Million ▼ -8.1 pp
2012 84.3% CN¥351.82 Million CN¥55.33 Million CN¥621.41 Million
pp = percentage points